Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
65.1M
-
Shares change
-
+801K
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$37.1M
-
Put/Call ratio
-
2.07
-
Number of buys
-
97
-
Number of sells
-
-79
-
Price
-
$29.06
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q3 2025
216 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q3 2025.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.1M shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (6.21M shares), BlackRock, Inc. (4.25M shares), Kynam Capital Management, LP (4.03M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.67M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (3.64M shares), VANGUARD GROUP INC (3.19M shares), FMR LLC (2.84M shares), Eversept Partners, LP (2.81M shares), Sofinnova Investments, Inc. (2.79M shares), and STATE STREET CORP (2.33M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.